Literature DB >> 2797351

Effect of deferoxamine mesylate on the growth of mucorales.

O Niimi1, A Kokan, N Kashiwagi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2797351     DOI： 10.1159/000185761

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  2 in total

1.  Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Authors:  J R Boelaert; M de Locht; J Van Cutsem; V Kerrels; B Cantinieaux; A Verdonck; H W Van Landuyt; Y J Schneider
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

2.  Siderophore production by pathogenic mucorales and uptake of deferoxamine B.

Authors:  Gérald Larcher; Marylène Dias; Bienvenue Razafimandimby; Danielle Bomal; Jean-Philippe Bouchara
Journal:  Mycopathologia       Date:  2013-08-28       Impact factor: 2.574
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.